Registration Type and Authorized Scope in Colombia

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The TIPO DE REGISTRO field on a Colombian registration certificate states the type of authorization and the authorized acts, not the risk class. Decreto 4725 de 2005 sets out three channels: the Registro Sanitario under Art. 16 (class IIb/III devices), the Registro Sanitario Automático under Art. 17 (class I/IIa devices), and the Permiso de Comercialización under Art. 23 and Art. 24 (controlled-technology biomedical equipment). Whichever authorization you obtain, you may only act within its corresponding scope.

GRZAN’s assessment is that the trap Chinese manufacturers most easily fall into is conflating importar y vender with local repackaging, labeling or assembly. Differences of this kind are not caught at the issuing stage, because the review looks at documents; they are flagged directly in post-grant verification – Article 57 of Ley 962 de 2005 requires INVIMA to carry out follow-up control within 15 days after issuance. Correcting the scope then means going through the change channel: COP 826,546 for a change of legal nature, COP 1,060,243 for a change of technical nature, plus the risk of suspended sales in the meantime.

A practical discipline is to read the issued certificate as a contract clause by clause: the entity, the act, the model list and the validity must each be checked against the application as filed. Any deviation found at this stage is a request for correction; the same deviation found a year later is a formal change with a fee attached.

2. Legal basis

RegulationNumberPublication dateProvision
Decreto 4725 de 2005 (medical device registration and vigilance system)Decreto 4725 de 2005December 26, 2005Art. 1 (scope; custom-made devices and IVD reagents excluded)
Decreto 4725 de 2005 (medical device registration and vigilance system)Decreto 4725 de 2005December 26, 2005Art. 16 (Registro Sanitario, class IIb/III)
Decreto 4725 de 2005 (medical device registration and vigilance system)Decreto 4725 de 2005December 26, 2005Art. 17 (Registro Sanitario Automático, class I/IIa)
Decreto 4725 de 2005 (medical device registration and vigilance system)Decreto 4725 de 2005December 26, 2005Art. 20 (contents of the certificate and authorized scope)
Decreto 4725 de 2005 (medical device registration and vigilance system)Decreto 4725 de 2005December 26, 2005Art. 23, Art. 24 (Permiso de Comercialización)
Decreto 4725 de 2005 (medical device registration and vigilance system)Decreto 4725 de 2005December 26, 2005Art. 48 (special import authorization for vital not available devices)
Decreto 582 de 2017 (amends 4725/2005)Decreto 582 de 2017April 4, 2017Post-grant verification, suspension and cancellation rules
Ley 962 de 2005 (anti-bureaucracy law)Ley 962 de 20052005Article 57 (follow-up control within 15 days after issuance)
Resolución 2025067543 (2026 fee schedule)Resolución 2025067543December 22, 2025Fee items for changes of legal and technical nature

3. Expert insights

#### The authorization type defines the acts, not the class

For the same product from the same company, entering through the class IIa automatic route and the class IIb standard route yields different scopes of authorized acts; controlled-technology biomedical equipment does not even receive a registration certificate but a Permiso de Comercialización. GRZAN requires clients at project initiation to define the acts first and only then the channel: for import and sale, use importar y vender; for any production inside Colombia, the corresponding qualifications of a manufacturing entity must be obtained separately – one import certificate cannot cover it.

#### Post-grant verification is the real test of the authorized acts

Automatic registration operates on a certificate-first, verify-later basis – class I/IIa review takes 2 business days and standard registration 90 business days, so certificates are issued far faster than on-site inspections can follow. Article 57 of Ley 962 de 2005 compresses the follow-up control to within 15 days after issuance, which makes obtaining the certificate and being verified nearly the same event. GRZAN’s view: every extra act written on the certificate is one more point to be verified; better to write the scope narrow at application than broad for appearance.

#### The special import channel cannot replace regular registration

The vital no disponibles mechanism of Art. 48 targets important devices with no domestic alternative; it is an ad hoc special import authorization, not a ticket to long-term commercialization. Used as a routine path, it will force you back to the standard registration channel at the second import, and none of the earlier time investment carries over.

4. Practical recommendations

  1. Manufacturer commercial team: at project initiation, define the list of acts in Colombia – import and sale only, or also repackaging, labeling or assembly.
  2. GRZAN regulatory team: derive the channel from the act list, determining whether Art. 16, Art. 17 or Art. 23/Art. 24 applies.
  3. Registration specialist: on receipt of the certificate, check the authorized acts field immediately against the initiation list item by item and request correction on the spot for any mismatch.
  4. Importer: keep the act descriptions on the customs documents consistent with the authorized acts on the certificate to avoid documentary conflicts.
  5. Compliance lead: prepare a response package for the post-grant follow-up control due within 15 days of issuance.
  6. Project management: reserve a change budget of COP 826,546 or COP 1,060,243 in case the authorized scope needs correction.

5. Verification checklist

  • □ The list of acts in Colombia was defined at project initiation
  • □ The channel chosen (Art. 16 / Art. 17 / Art. 23–Art. 24) matches the act list
  • □ The authorized acts field on the certificate matches the initiation list item by item
  • □ Acts not written on the certificate (repackaging, labeling, assembly) have separate qualification planning
  • □ Customs document descriptions match the authorized acts on the certificate
  • □ Response materials for the follow-up control within 15 days of issuance are ready
  • □ The change budget is reserved at both levels of COP 826,546 and COP 1,060,243
  • □ The Art. 48 special import mechanism is not being used as a long-term commercialization path
  • GRZAN regulatory team

Regulatory information verified as of October 29, 2026

All conclusions published here are based on the current regulatory texts issued by the competent authority and are verified item by item before delivery.

GRZAN advises manufacturers on choosing the right INVIMA authorization channel for the Colombian market, defining authorized acts before filing, and budgeting registration and change fees under the 2026 fee schedule, together with local licensed-entity and importer support. For a scope review before you file, contact us at info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail